Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Clemens Lange

Showing results (11-20 of 100) with videos related to

Pageof 10
Sort By:
Current Opinion in Ophthalmology|February 10, 2025
Tissue engineering of the vitreous body: recent progress and future trendsAndré Schulz, Stefaniya K Boneva, Clemens Lange, et al.
Die Ophthalmologie|February 10, 2025
[Secondary choroidal neovascularization-Really so common?]Ulrike Brocks, Martin Ziegler, Clemens Lange, et al.
Ocular Oncology and Pathology|January 19, 2018
Corneal Myofibroma (Keloid) in a Young Patient with Neurofibromatosis Type 2Lisa Zimmermann, Thomas Reinhard, Clemens Lange, et al.
Biomedicines|April 23, 2022
The Role of Osteopontin in Microglia Biology: Current Concepts and Future PerspectivesDennis-Dominik Rosmus, Clemens Lange, Franziska Ludwig, et al.
Die Ophthalmologie|February 23, 2022
[Web-based gene expression analysis-paving the way to decode healthy and diseased ocular tissue]Julian Wolf, Thabo Lapp, Thomas Reinhard, et al.
Journal of Personalized Medicine|June 25, 2025
Morphology of Macular Neovascularization in Age-Related Macular Degeneration Influences Treatment Requirement and Visual Outcome After 1 YearMichael Grün, Kai Rothaus, Martin Ziegler, et al.
Die Ophthalmologie|September 13, 2022
Web-based gene expression analysis-paving the way to decode healthy and diseased ocular tissueJulian Wolf, Thabo Lapp, Thomas Reinhard, et al.
Diagnostics (Basel, Switzerland)|May 1, 2025
The Vascular Architecture of Macular Neovascularization in Age-Related Macular Degeneration as a Predictor of Therapy Requirements: A 3-Year Longitudinal AnalysisMichael Grün, Kai Rothaus, Martin Ziegler, et al.
JAMA Ophthalmology|May 10, 2014
Neuroendocrine tumor of the eyelid: a clinicopathological case reportClemens Lange, Annette Schmitt-Graeff, Hans Mittelviefhaus, et al.
Retina (Philadelphia, Pa.)|January 23, 2024
METHYLATION-ASSOCIATED PATHWAYS IN MACULAR TELANGIECTASIA TYPE 2 AND OPHTHALMOLOGIC FINDINGS IN PATIENTS WITH GENETIC METHYLATION DISORDERSLaurenz Pauleikhoff, Victoria Wingert, Sarah C Grünert, et al.
Pageof 10

Showing results (11-20 of 100) with videos related to

Sort By:
Pageof 10
Current Opinion in Ophthalmology|February 10, 2025
Tissue engineering of the vitreous body: recent progress and future trendsAndré Schulz, Stefaniya K Boneva, Clemens Lange, et al.
Die Ophthalmologie|February 10, 2025
[Secondary choroidal neovascularization-Really so common?]Ulrike Brocks, Martin Ziegler, Clemens Lange, et al.
Ocular Oncology and Pathology|January 19, 2018
Corneal Myofibroma (Keloid) in a Young Patient with Neurofibromatosis Type 2Lisa Zimmermann, Thomas Reinhard, Clemens Lange, et al.
Biomedicines|April 23, 2022
The Role of Osteopontin in Microglia Biology: Current Concepts and Future PerspectivesDennis-Dominik Rosmus, Clemens Lange, Franziska Ludwig, et al.
Die Ophthalmologie|February 23, 2022
[Web-based gene expression analysis-paving the way to decode healthy and diseased ocular tissue]Julian Wolf, Thabo Lapp, Thomas Reinhard, et al.
Journal of Personalized Medicine|June 25, 2025
Morphology of Macular Neovascularization in Age-Related Macular Degeneration Influences Treatment Requirement and Visual Outcome After 1 YearMichael Grün, Kai Rothaus, Martin Ziegler, et al.
Die Ophthalmologie|September 13, 2022
Web-based gene expression analysis-paving the way to decode healthy and diseased ocular tissueJulian Wolf, Thabo Lapp, Thomas Reinhard, et al.
Diagnostics (Basel, Switzerland)|May 1, 2025
The Vascular Architecture of Macular Neovascularization in Age-Related Macular Degeneration as a Predictor of Therapy Requirements: A 3-Year Longitudinal AnalysisMichael Grün, Kai Rothaus, Martin Ziegler, et al.
JAMA Ophthalmology|May 10, 2014
Neuroendocrine tumor of the eyelid: a clinicopathological case reportClemens Lange, Annette Schmitt-Graeff, Hans Mittelviefhaus, et al.
Retina (Philadelphia, Pa.)|January 23, 2024
METHYLATION-ASSOCIATED PATHWAYS IN MACULAR TELANGIECTASIA TYPE 2 AND OPHTHALMOLOGIC FINDINGS IN PATIENTS WITH GENETIC METHYLATION DISORDERSLaurenz Pauleikhoff, Victoria Wingert, Sarah C Grünert, et al.
Pageof 10